Cargando…

Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment

OBJECTIVE: The aim of the study reported here was to investigate the protective effect of gonadotropin-releasing hormone analog (GnRHa) against cyclophosphamide (CTX)-induced gonadotoxicity. METHODS: Eighty Fischer 344 rats were divided randomly into four groups (20 per group). One group received no...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Ting, Yuan, Guangwen, Shen, Keng, Cao, Dongyan, Yang, Jiaxin, Wu, Ming, Lang, Jinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376258/
https://www.ncbi.nlm.nih.gov/pubmed/25848306
http://dx.doi.org/10.2147/OTT.S78729
_version_ 1782363713677819904
author Gui, Ting
Yuan, Guangwen
Shen, Keng
Cao, Dongyan
Yang, Jiaxin
Wu, Ming
Lang, Jinghe
author_facet Gui, Ting
Yuan, Guangwen
Shen, Keng
Cao, Dongyan
Yang, Jiaxin
Wu, Ming
Lang, Jinghe
author_sort Gui, Ting
collection PubMed
description OBJECTIVE: The aim of the study reported here was to investigate the protective effect of gonadotropin-releasing hormone analog (GnRHa) against cyclophosphamide (CTX)-induced gonadotoxicity. METHODS: Eighty Fischer 344 rats were divided randomly into four groups (20 per group). One group received normal saline, one GnRHa, one CTX, and one GnRHa+CTX. Several parameters were used to observe the ovarian reserve, including ovary weight, follicle number and diameter, concentrations of estradiol (E(2)) and follicle-stimulating hormone (FSH), and expressions of sex hormone receptors. RESULTS: When treatment was finished, the number of small follicles in the GnRHa+CTX group was significantly higher than in the CTX-alone group. Thirty days after treatment, the ovary weight, percentage of small follicles, mean follicular diameter, and serum concentrations of E(2) and FSH in the GnRHa+CTX group all recovered, approaching normal levels. Sex hormone receptors did not show significant differences between the four groups. CONCLUSION: Combination treatment with GnRHa could prevent CTX-induced damage to ovarian reserve.
format Online
Article
Text
id pubmed-4376258
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43762582015-04-06 Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment Gui, Ting Yuan, Guangwen Shen, Keng Cao, Dongyan Yang, Jiaxin Wu, Ming Lang, Jinghe Onco Targets Ther Original Research OBJECTIVE: The aim of the study reported here was to investigate the protective effect of gonadotropin-releasing hormone analog (GnRHa) against cyclophosphamide (CTX)-induced gonadotoxicity. METHODS: Eighty Fischer 344 rats were divided randomly into four groups (20 per group). One group received normal saline, one GnRHa, one CTX, and one GnRHa+CTX. Several parameters were used to observe the ovarian reserve, including ovary weight, follicle number and diameter, concentrations of estradiol (E(2)) and follicle-stimulating hormone (FSH), and expressions of sex hormone receptors. RESULTS: When treatment was finished, the number of small follicles in the GnRHa+CTX group was significantly higher than in the CTX-alone group. Thirty days after treatment, the ovary weight, percentage of small follicles, mean follicular diameter, and serum concentrations of E(2) and FSH in the GnRHa+CTX group all recovered, approaching normal levels. Sex hormone receptors did not show significant differences between the four groups. CONCLUSION: Combination treatment with GnRHa could prevent CTX-induced damage to ovarian reserve. Dove Medical Press 2015-03-23 /pmc/articles/PMC4376258/ /pubmed/25848306 http://dx.doi.org/10.2147/OTT.S78729 Text en © 2015 Gui et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Gui, Ting
Yuan, Guangwen
Shen, Keng
Cao, Dongyan
Yang, Jiaxin
Wu, Ming
Lang, Jinghe
Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
title Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
title_full Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
title_fullStr Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
title_full_unstemmed Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
title_short Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
title_sort protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376258/
https://www.ncbi.nlm.nih.gov/pubmed/25848306
http://dx.doi.org/10.2147/OTT.S78729
work_keys_str_mv AT guiting protectiveeffectofgonadotropinreleasinghormoneanalogontheovarianreserveinratsreceivingcyclophosphamidetreatment
AT yuanguangwen protectiveeffectofgonadotropinreleasinghormoneanalogontheovarianreserveinratsreceivingcyclophosphamidetreatment
AT shenkeng protectiveeffectofgonadotropinreleasinghormoneanalogontheovarianreserveinratsreceivingcyclophosphamidetreatment
AT caodongyan protectiveeffectofgonadotropinreleasinghormoneanalogontheovarianreserveinratsreceivingcyclophosphamidetreatment
AT yangjiaxin protectiveeffectofgonadotropinreleasinghormoneanalogontheovarianreserveinratsreceivingcyclophosphamidetreatment
AT wuming protectiveeffectofgonadotropinreleasinghormoneanalogontheovarianreserveinratsreceivingcyclophosphamidetreatment
AT langjinghe protectiveeffectofgonadotropinreleasinghormoneanalogontheovarianreserveinratsreceivingcyclophosphamidetreatment